Tal Teitz, PhD, assistant professor in the School of Medicine Department of Pharmacology and Neuroscience, has been awarded a $45,000 grant from the American Hearing Research Foundation for her research project “Repurposing an FDA Approved Drug Dabrafenib for protection from Noise-induced Hearing Loss.” Hearing loss caused by noise exposure and aging is a major unmet medical need in our society, affecting over 600 million people worldwide. In this study, the Teitz Research group identified a top compound that protected mice significantly against noise-induced hearing loss. The drug is orally bioavailable, and FDA approved for treatment in humans against several cancers. The study will identify the optimum regimen of dabrafenib treatment for noise protection in mice for clinical studies in humans.
Teitz Awarded American Hearing Research Foundation Grant
– January 16, 2020Posted in: Faculty/Staff News, School of Medicine
